Extracorporeal life support in pregnant and postpartum women with COVID-19-related acute respiratory distress syndrome.
Ahmed M El BanayosyAly El BanayosyJennifer G SmithJoseph M BrewerMircea R MihuLaura V SwantRobert S SchoapsAmmar SharifClayne BensonMarc O MaybauerPublished in: The International journal of artificial organs (2023)
Our study shows a 100% neonatal and maternal survival rate demonstrating that ECMO in this patient population is safe. These patients should be transferred to experienced high-volume ECMO centers with the ability to perform emergent cesarean sections. ECMO should be considered a life-saving therapy for pregnant women with severe COVID-19 with an overall excellent maternal and neonatal survival rate.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- coronavirus disease
- sars cov
- end stage renal disease
- pregnant women
- newly diagnosed
- ejection fraction
- respiratory failure
- birth weight
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- free survival
- early onset
- pregnancy outcomes
- patient reported outcomes